Bensen S, Mott L A, Dain B, Rothstein R, Baron J
Section of Gastroenterology, White River Junction VA Medical and Regional Office Center, Vermont, USA.
Am J Gastroenterol. 1999 Jan;94(1):194-9. doi: 10.1111/j.1572-0241.1999.00796.x.
Studies of tandem colonoscopies have reported that 15-25% of neoplastic polyps <1 cm in size and 0-6% of larger polyps are overlooked at the time of colonoscopy. We determined the miss rate and "true" 1-yr recurrence of neoplastic polyps in a population of patients reflecting a broad spectrum of different gastroenterology practice settings.
Patient data from several sources were examined for repeat colonoscopies performed on the same patient within 120 days of each other. Examination pairs were included for analysis if both colonoscopies had good preps and reached the cecum. The miss rate was calculated by two methods: 1) a pooled rate, the total number of polyps on all second examinations divided by the total number on both examinations, and 2) a within-person rate, the average of the individual miss-rates. We estimated a "true" 1-yr recurrence rate by subtracting the proportion of patients with a missed neoplastic polyp from the proportion of patients with a neoplastic polyp found at 1 yr.
A total of 76 colonoscopy pairs a mean 47 days apart (range, 1-119 days) were identified from a total of approximately 15,000 examinations and used to calculate the overall miss rates. For the category "all polyps" (neoplastic and nonneoplastic polyps), 17% by the pooled method and 11% by the within-person method were missed. The corresponding rates for neoplastic polyps were 12% by the pooled method and 8% by the within-person method. A total of 17% of patients had one or more neoplastic polyps missed on the initial examination. The observed 1-yr recurrence rate was determined from 1,314 colonoscopy pairs performed a mean of 379 days apart and found to be 28% for neoplastic polyps. By comparing this to the proportion of patients with one or more missed neoplastic polyps, we found the true 1-yr recurrence of neoplastic polyps to be 11%.
There is a significant colonoscopic miss rate for neoplastic polyps and "all polyps" in clinical practice that is comparable to that previously stated in special research settings. The within-person rate more accurately reflects the true colorectal polyp miss rate for any given colonoscopic exam than does the pooled rate. The difference between the observed 1-yr recurrence rate and the proportion of patients with a missed polyp represents the true 1-yr recurrence of neoplastic polyps.
关于串联结肠镜检查的研究报告称,在结肠镜检查时,15% - 25%的直径小于1 cm的肿瘤性息肉以及0% - 6%的较大息肉会被漏诊。我们在反映广泛不同胃肠病学实践环境的患者群体中,确定了肿瘤性息肉的漏诊率和“真正的”1年复发率。
检查来自多个来源的患者数据,以查找在彼此120天内对同一患者进行的重复结肠镜检查。如果两次结肠镜检查准备充分且均到达盲肠,则将这些检查对纳入分析。漏诊率通过两种方法计算:1)合并率,即所有第二次检查中息肉总数除以两次检查中息肉总数;2)个体内率,即个体漏诊率的平均值。我们通过从1年时发现有肿瘤性息肉的患者比例中减去漏诊肿瘤性息肉的患者比例,来估计“真正的”1年复发率。
从总共约15000次检查中识别出76对结肠镜检查,平均间隔47天(范围1 - 119天),并用于计算总体漏诊率。对于“所有息肉”(肿瘤性和非肿瘤性息肉)类别,合并法得出的漏诊率为17%,个体内法为11%。肿瘤性息肉的相应比例,合并法为12%,个体内法为8%。共有17%的患者在初次检查时漏诊了一个或多个肿瘤性息肉。观察到的1年复发率是根据平均间隔379天进行的1314对结肠镜检查确定的,发现肿瘤性息肉的复发率为28%。通过将此与有一个或多个肿瘤性息肉漏诊的患者比例进行比较,我们发现肿瘤性息肉真正的1年复发率为11%。
在临床实践中,肿瘤性息肉和“所有息肉”的结肠镜漏诊率较高,与先前在特殊研究环境中所述的漏诊率相当。个体内率比合并率更准确地反映了任何给定结肠镜检查中结直肠息肉的真实漏诊率。观察到的1年复发率与有息肉漏诊的患者比例之间的差异代表了肿瘤性息肉真正的1年复发率。